NRX Pharmaceuticals, Inc. - Common Stock NRXP 深 沪
等待开盘 08-16 09:30:00 美东时间
2.89
+0.220
+8.24%
华盛通- 最 高2.95
- 今 开2.76
- 成交量 57.08万股
- 最 低 2.6001
- 昨 收 2.67
- 总市值 5636.48万
- 52周最高 6.01
- 市盈率 静 --
- 换手率 2.93%
- 52周最低 1.10
- 委 比 -38.89%
- 总股本 1950.34万
- 历史最高 769.90
- 量 比 0.88
- 振 幅 13.10%
- 历史最低 1.58
- 每 手 1
- 风险率 0.81%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Insights Ahead: NRX Pharmaceuticals's Quarterly Earnings
NRX Pharmaceuticals (NASDAQ:NRXP) is gearing up to announce its quarterly earni...
08-14 02:03
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target
D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $31 price target.
08-11 20:22
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Report Second Quarter 2025 Financial Results on August 14, 2025
NRx Pharmaceuticals announced it will release its second quarter 2025 financial results on August 14, 2025, followed by a conference call at 4:30pm ET. The call will discuss recent regulatory events, strategy, and future plans. A live webcast will be available on the company's website, with dial-in numbers provided for participants. NRx focuses on developing therapeutics for CNS disorders, with NRX-100 and NRX-101 targeting suicidal depression, c...
08-11 20:05
NRx Pharmaceuticals (NASDAQ: NRXP) Petitions FDA to Ban Benzethonium Chloride from Ketamine Products
Austin, Texas, United States, August 4th, 2025, FinanceWire Austin, Texas, Unit...
08-04 23:00
NRx Pharmaceuticals (NASDAQ: NRXP) Charts Dual-Path for NRX-100
Austin, Texas, United States, July 21st, 2025, FinanceWire NRx Pharmaceuticals ...
07-22 01:00
美股大行评级 | 潜在涨幅378.93%！aTyr Pharma获富国银行升目标价至25美元，维持"超配"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1143101010774646784.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 富国银行：维持aTyr Pharma(ATYR)"超配"评级，目标价从17美元升至25美元</p> <p>• 摩根大通：维持Array Technologies(ARRY)"超配"评级，目标价从12美元升至13美元</p>
06-21 08:35
D. Boral Capital Maintains Buy on NRX Pharmaceuticals, Maintains $31 Price Target
D. Boral Capital analyst Jason Kolbert maintains NRX Pharmaceuticals (NASDAQ:NRXP) with a Buy and maintains $31 price target.
06-20 23:42
NRx Pharmaceuticals And HOPE Therapeutics Announce Strategic Investor Relations Partnership With Life Sciences Advisory Firm Astr Partners
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, and HOPE Therapeutics, Inc., ("HOPE," or the "Company"), a multi-site clinical care
06-16 20:15
Nurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Nurix Therapeutics announced on June 10, 2025, that it granted inducement awards to 17 new employees under its 2024 Equity Inducement Plan. The awards include stock options for 97,400 shares and restricted stock units (RSUs) for 66,750 shares. Stock options vest over four years, with 1/4 vesting after the first year and 1/48 each month thereafter. RSUs vest with 1/4 after one year and 1/16 quarterly thereafter. The options have a 10-year term wit...
06-13 20:01
